Application segmentation reveals three dominant end‑use categories: cosmetics, pharmaceuticals, and food & beverages. Cosmetics dominate the market, representing approximately 45 % of total demand, primarily as a preservative in creams, lotions, and sunscreens where regulatory limits favor methyl 4‑hydroxybenzoate for its broad antimicrobial spectrum. The pharmaceutical segment follows with an estimated 35 % share, employed in topical formulations, oral suspensions, and as a stabilizer in vaccine adjuvants, where stringent purity criteria drive higher unit values. Food & beverage applications, though constrained by regional additive bans, still account for about 20 % of volume, chiefly in bakery products and low‑acid beverages where it extends shelf life. These application shares underpin the overall market size, guiding capacity planning and R&D focus. Precise quantification of each application’s contribution is a core component of the market taxonomy used by analysts to model growth trajectories for the Methyl 4‑Hydroxybenzoate market.